Quinapril D5
| Product Name | Quinapril D5 |
|---|---|
| Alternate Names | Quinapril Stable Isotopes, Stable Isotopes of Quinapril |
| CAT No. | CS-O-14665 |
| CAS No. | 1279029-79-6 |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 443.55 g/mol |
| Mol. For. | C₂₅H₂₅D₅N₂O₅ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Quinapril |
| Purity | >98% |
| Therapeutic | Anti-Hypertensives |
| Smileys | O=C(N(CC1=CC=CC=C1C2)[C@@H]2C(O)=O)[C@H](C)N[C@H](C(OCC)=O)CCC(C([2H])=C3[2H])=C(C([2H])=C3[2H])[2H] |
| Canonical Smiles | CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3=CC=CC=C3CC2C(=O)O |
| InchIKey | JSDRRTOADPPCHY-BNPIMZLHSA-N |
| Inchl | InChI=1S/C25H30N2O5/c1-3-32-25(31)21(14-13-18-9-5-4-6-10-18)26-17(2)23(28)27-16-20-12-8-7-11-19(20)15-22(27)24(29)30/h4-12,17,21-22,26H,3,13-16H2,1-2H3,(H,29,30)/t17-,21-,22-/m0/s1/i4D,5D,6D,9D,10D |
| IUPAC | (3S)-2-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-(2,3,4,5,6-pentadeuteriophenyl)butan-2-yl]amino]propanoyl]-3,4-dihydro-1H-isoquinoline-3-carboxylic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Quinapril D5 is a stable isotopic labeled form of Quinapril, a medication used to treat high blood pressure and heart failure. It belongs to a class of drugs called ACE inhibitors, which work by inhibiting the action of an enzyme that causes blood vessels to constrict. This results in the relaxation of blood vessels, allowing blood to flow more easily and reducing the workload on the heart.
The chemical formula of Quinapril D5 is C25H29D5N2O5, and its molecular weight is 442.6 g/mol. It is administered orally in the form of tablets and is generally well-tolerated by patients. The recommended dosage varies depending on the patient's condition, age, and other factors.
Quinapril D5 is metabolized in the liver by the cytochrome P450 enzyme system, with the primary metabolite being quinaprilat. The elimination half-life of Quinapril D5 is approximately 2 hours, and its clearance is mainly through renal excretion.
Like other ACE inhibitors, Quinapril D5 may cause side effects such as cough, dizziness, headache, and fatigue. It may also interact with other medications, so it is important to inform your doctor of any other drugs you are taking.
In conclusion, Quinapril D5 is a medication used to treat high blood pressure and heart failure by relaxing blood vessels and reducing the workload on the heart. Its chemical formula, metabolism, and elimination half-life make it an effective and well-tolerated treatment option for patients.
Get an Instant Quote
Related Compounds
Quinaprilat d5 | Quinapril D4 | Quinapril D5 hydrochloride | N-Nitroso Quinapril-d5 |